Showing results (51-60 of 197) with videos related to
Sort By:
Pageof 20
Rare Diseases (Austin, Tex.)|July 9, 2014
Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assemblyJames Shorter, J Paul TaylorTrends in Genetics : TIG|February 8, 2021
Open Access: A Role for p53 in c9ALS/FTD?Charlotte M Fare, James ShorterBiochimica Et Biophysica Acta|August 17, 2011
The elusive middle domain of Hsp104 and ClpB: location and functionMorgan E Desantis, James ShorterCell Cycle (Georgetown, Tex.)|April 4, 2014
Reversing deleterious protein aggregation with re-engineered protein disaggregasesMeredith E Jackrel, James ShorterDisease Models & Mechanisms|July 27, 2014
Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteinsMeredith E Jackrel, James ShorterCell|April 15, 2022
Flying under the radar: TMEM106B(120-254) fibrils break out in diverse neurodegenerative disordersKatie E Copley, James ShorterNature Communications|May 31, 2022
Dynamic arrest and aging of biomolecular condensates are modulated by low-complexity domains, RNA and biochemical activityMiriam Linsenmeier, Maria Hondele, Fulvio Grigolato, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 24, 2020
Examination of SOD1 aggregation modulators and their effect on SOD1 enzymatic activity as a proxy for potential toxicityRavinder Malik, Christian Corrales, Miriam Linsenmeier, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 5, 2010
Applying Hsp104 to protein-misfolding disordersShilpa Vashist, Mimi Cushman, James ShorterBio-Protocol|March 4, 2021
Karyopherin-β2 Inhibits and Reverses Aggregation and Liquid-liquid Phase Separation of the ALS/FTD-Associated Protein FUSEmma Robinson, James Shorter, Lin GuoPageof 20